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capable of internalizing lipoproteins, via LOX-1 (lectin-like oxidized low
density lipoprotein receptor 1). Once cholesterol is accumulated in cells, its
eﬄux is mediated through reverse cholesterol transport via nuclear factors
LXRa and LXRβ (liver X receptors) and the ATP-binding-cassette transporter
A1 (ABCA1) gene. ABCA1 serves as a lipid pump that eﬄuxes cholesterol
from cells to apolipoprotein A1 (ApoA1). As the accumulation of lipids
in chondrocytes may signify a causal relationship to development and/or
progression of OA, we investigated the expression of genes regulating
reverse cholesterol transport, as ABCA1, ApoA1, LXRa and LXRβ in human
chondrocytes. We also investigated the effect of a synthetic LXR agonist on
apoptosis, ABCA1 and ApoA1 mRNA expression, lipid accumulation, as well
as on COL2A1, AGC, MMP-3, MMP-13 and IL-6 expression levels.
Methods: Articular cartilage samples were obtained from 27 patients with
primary OA undergoing knee replacement surgery, while normal cartilage
was obtained from 8 individuals undergoing fracture repair surgery, with no
history of joint disease. Total cellular RNA was extracted from all samples
and ABCA1, ApoA1, LXRα and LXRβ mRNA and protein expression levels
were evaluated using real-time PCR and Western blot analysis respectively.
The effect of the synthetic LXR agonist TO-901317 was studied after
treatment of osteoarthritic chondrocytes and subsequent investigation of
ABCA1, ApoA1, MMP-13, MMP-3 as well as COL2A1 and AGC mRNA expres-
sion levels. IL-6 was measured with ELISA. Cholesterol eﬄux was evaluated
in osteoarthritic chondrocytes radiolabeled with [1,2(n)-3H] cholesterol
after LXR treatment, while intracellular lipid accumulation was studied
after Oil-red-O staining. Apoptosis was evaluated using ﬂow cytometry.
Results: We found that ApoA1 and ABCA1 mRNA and protein expression
levels were signiﬁcantly lower in osteoarthritic compared to normal carti-
lage (p<0.01 and p<0.001 respectively). In addition, LXRα and LXRβ mRNA
expression levels were also found to be signiﬁcantly lower in osteoarthritic
cartilage (p<0.05 and p<0.01 respectively). Treatment of osteoarthritic
chondrocytes with the LXR agonist TO-901317 resulted in: (i) signiﬁcantly
increased ApoA1 and ABCA1 mRNA expression levels (p<0.01), (ii) signiﬁ-
cant increase in cholesterol eﬄux (p<0.05) (iii) elimination of intracellular
lipids deposits, which had been observed before agonist treatment (iv)
signiﬁcant reduction of MMP-3 and MMP-13 protein levels (p<0.001 and
p<0.01, respectively), (v) signiﬁcant increase by 2 and 6.6-fold in COL2A1
and AGC mRNA expression levels (p<0.05), (vi) signiﬁcant decrease in IL-6
levels (p<0.01) and (vii) signiﬁcant reduction of apoptosis (p<0.005).
Conclusions: Our ﬁndings suggest that impaired expression of genes reg-
ulating cholesterol eﬄux may be a critical player in osteoarthritis, while
the ability of the LXR agonist to facilitate cholesterol eﬄux, results in
reduction of catabolic and inﬂammatory molecules and increase in anabolic
genes’ expression, suggesting its potential use for therapeutic intervention
in osteoarthritis.
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Purpose: The majority of long bones develop through a process called
endochondral ossiﬁcation, which involves strict coordination of chondro-
cyte proliferation, differentiation and apoptosis within the growth plate,
thus resulting in the replacement of cartilage by bone. Interplay of the
multitude of intracellular and extracellular factors acting from within and
on chondrocytes results in very tight regulation of these processes, and dis-
turbances of the ﬁne balance controlling endochondral bone growth results
in growth and development-related abnormalities such as dwarﬁsm and
skeletal deformities. The exact mechanisms through which chondrocyte
function/behaviour is controlled during cartilage growth and development
are largely unknown. Peroxisome proliferator-activated receptor gamma
(PPARγ), a transcription factor, plays a key role in lipid homeostasis and
recent studies suggest that PPARγ is involved in the maintenance of bone
homeostasis by contributing to osteoclastogenic and osteoblastogenic path-
ways. However, the speciﬁc in vivo function of PPARγ in chondrogenesis,
and cartilage growth and development is largely unknown. Therefore,
for the ﬁrst time, my study will examine the speciﬁc in vivo contri-
bution of PPARγ to cartilage growth and development processes using
cartilage-speciﬁc PPARγ knockout (KO) mice.
Methods: Cartilage-speciﬁc PPARγ-deﬁcient mice were generated using the
Lox P/Cre system. Using mice at post-natal day zero (P0) and embryonic
16.5 days old (E16.5), the following techniques were used: (1) Histological
staining of long bones with Safranin-O/Fast Green stain to determine the
role of PPARγ in ossiﬁcation patterns, chondrocyte cell shape, and organi-
zation of growth plates. (2) Staining of whole skeletons of newborn mice
with alcian blue/alizarin red to determine skeletal phenotypic changes. (3)
Real-Time PCR and western blotting to determine the expression of extra-
cellular matrix (ECM) markers. (4) Immunohistochemistry for Collagen X
(to determine formation of osseous center), p57 (a marker of hypertrophic
differentiation), and PECAM (cell surface marker for endothelial cells to
account for vascularization).
Results: Newborn wild-type (WT) mice showed that PPARγ is expressed in
all zones of the growth plate of tibias. Although cartilage-speciﬁc PPARγ
KO mice were viable and healthy at least three weeks post-birth, they
showed reduced length, weight, skeletal growth and length of long bones at
birth compared to WT mice. Newborn heterozygous (het) and homozygous
(hom) cartilage-speciﬁc PPARγ KO mice showed growth plate abnormalities
including abnormal growth plate organization and cell shape, reduced cel-
lularity, loss of columnar organization, and shorter hypertrophic zones in a
gene-dose dependent manner. Additionally, immunohistochemistry for p57
showed reduced chondrocyte differentiation in het and hommice compared
to WT mice. Immunohistochemistry for PECAM and Collagen X in long
bones of E16.5 mice revealed reduced vascularity and delayed formation
of osseous center in PPARγ KO mice compared to WT mice. Furthermore,
in vitro studies using PPARγ-deﬁcient chondrocytes showed increased ex-
pression of ECM degradation products including matrix metalloproteinase
(MMP)-13 and ADAMTS-5 (aggrecanase), and decreased expression of ECM
building products including aggrecan and type-II collagen.
Conclusions: This is the ﬁrst report to demonstrate that PPARγ-deﬁciency
in cartilage results in growth plate abnormalities. Overall, we show that
PPARγ plays a potential role in cartilage growth and development in vivo
and its deﬁciency will result in serious musculoskeletal deformities in vivo.
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Purpose: Osteoarthritis is a disease characterized by destruction and failure
of the extracellular matrix, which serves as the functional component of
the articular cartilage. The production of extracellular matrix is solely
dependent on the chondrocytes, which makes up the only cell type in the
articular cartilage. Therefore, chondrocyte death and survival are essential
for maintaining the articular cartilage. Transglutaminase 2 (TGase 2) is
an enzyme catalyzing Ca2+-dependent protein cross-linking. TGase 2 has
been shown to be induced and activated during apoptosis. We have previ-
ously shown that TGase 2 expression is increased in human chondrocytes
undergoing apoptosis. Furthermore, inhibition of TGase 2 by monodansyl-
cadaverine (MDC); a competitive substrate of TGase 2; and TGase 2 siRNA
have increased chondrocyte apoptosis. These ﬁndings suggested a possible
protective role of TGase 2 in chondrocyte apoptosis. Retinoic acid (RA) and
its various synthetic analogs affect mammalian cell growth, differentiation,
and apoptosis. RA consistently induces TGase 2 expression and activation,
and it was recently shown that increased TGase 2 expression protected
NIH3T3 cells from apoptosis. The purpose of this study was to demonstrate
whether TGase 2 is induced in human chondrocytes with RA and explore
the role of TGase 2 in human chondrocyte apoptosis.
Methods: 1. Human chondrocytes culture and apoptosis assay. Human
chondrocyte culture, apoptosis induction and analysis of TGase 2 expres-
sion was performed as previously described. Brieﬂy, human chondrocytes
were obtained from the articular cartilage of patients undergoing total
knee arthroplasty and cultured in monolayer. Chondrocyte apoptosis was
induced by treating with H2O2 (1mM) for 24 hours. Apoptosis was as-
sessed by two methods, biochemically by Annexin-V FACS analysis, and
morphologically by nuclear staining for 4’6-Diamidine-2’-phenylliondole
(DAPI).
2. RA treatment. Human chondrocytes were grown in medium containing
10% bovine serum and 1% streptopenicillin at 37°C in a humidiﬁed incuba-
tor with 5% CO2. The cells were starved in medium containing 1% serum
for 48 hours prior to the treatment with 5 μM RA.
